The Prevalence, Clinical, and Molecular Characteristics of Congenital Hypothyroidism Caused by DUOX2 Mutations: A Population-Based Cohort Study in Guangzhou

 

 Buy Article Permissions and Reprints

Abstract

Thyroid dyshormonogenesis (DH) has recently been reported to be more frequently associated with mutations in the dual oxidase 2 (DUOX2) gene. The present study was aimed to investigate the prevalence, clinical, and molecular characteristics of congenital hypothyroidism (CH) caused by DUOX2 mutations in Guangzhou. A population-based cohort of 156 patients with CH was recruited based on neonatal screening among 433 578 newborns born in Guangzhou from 2011 to 2012. Genetic analysis of DUOX2 was performed in 96 patients with suspected thyroid dyshormonogenesis (SDH) by PCR-amplified direct sequencing. Apart from 2 cases without ultrasonographic data, 118 (76.6%) of the 156 patients were classified as SDH and 36 (23.4%) as thyroid dysgenesis (TD) according to thyroid ultrasound at diagnosis. Genetic analysis revealed 23 different variants in 60 unrelated individuals (60/96, 62.5%), including 13 novel variants that were absent from HGMD, dbSNP databases, and the 50 normal controls. The novel missense variants were predicted to be pathogenic by SIFT and PolyPhen-2. The p.K530X was the most common mutation. Ninety-three percent of mutant alleles occurred in exons 5, 6, 9, 14, 17, 20, 25, 27, and 28. There were no significant differences in phenotypes between biallelic and monoallelic variants cases or between with-DUOX2 and non-DUOX2 variants cases. Most patients with DUOX2 defects (78.2%) were transient CH. In conclusion, the prevalence of DUOX2 pathogenic variants was high (62.5%) in this cohort. Thirteen novel probably pathologic variants were reported. The p.K530X was the most common mutation in the Chinese population. There was no correlation between DUOX2 genotypes and clinical phenotypes.

• References

• 1 Wassner AJ, Brown RS. Congenital hypothyroidism: recent advances. Curr Opin Endocrinol Diabetes Obes 2015; 22: 407-412
  CrossrefPubMedGoogle Scholar
• 2 De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 2004; 25: 722-746
  CrossrefPubMedGoogle Scholar
• 3 Corbetta C, Weber G, Cortinovis F, Calebiro D, Passoni A, Vigone MC, Beck-Peccoz P, Chiumello G, Persani L. A 7-year experience with low blood TSH cutoff levels for neonatal screening reveals an unsuspected frequency of congenital hypothyroidism (CH). Clin Endocrinol (Oxf) 2009; 71: 739-745
  CrossrefPubMedGoogle Scholar
• 4 Nagasaki K, Asami T, Ogawa Y, Kikuchi T, Uchiyama M. A study of the etiology of congenital hypothyroidism in the Niigata prefecture of Japan in patients born between 1989 and 2005 and evaluated at ages 5-19. Thyroid 2011; 21: 361-365
  CrossrefPubMedGoogle Scholar
• 5 Hashemipour M, Ghasemi M, Hovsepian S, Heiydari K, Sajadi A, Hadian R, Mansourian M, Mirshahzadeh N, Kelishadi R, Dalvi M. Etiology of congenital hypothyroidism in Isfahan: Does it different?. Adv Biomed Res 2014; 3: 21
  CrossrefPubMedGoogle Scholar
• 6 Albert BB, Cutfield WS, Webster D, Carll J, Derraik JG, Jefferies C, Gunn AJ, Hofman PL. Etiology of increasing incidence of congenital hypothyroidism in New Zealand from 1993-2010. J Clin Endocrinol Metab 2012; 97: 3155-3160
  CrossrefPubMedGoogle Scholar
• 7 Castanet M, Goischke A, Leger J, Thalassinos C, Rodrigue D, Cabrol S, Zenaty D, Al-Harbi M, Polak M, Czernichow P. Natural history and management of congenital hypothyroidism with in situ thyroid gland. Horm Res Paediatr 2015; 83: 102-110
  CrossrefPubMedGoogle Scholar
• 8 Mitrovic K, Vukovic R, Milenkovic T, Todorovic S, Radivojcevic J, Zdravkovic D. Changes in the incidence and etiology of congenital hypothyroidism detected during 30 years of a screening program in central Serbia. Eur J Pediatr 2016; 175: 253-259
  CrossrefPubMedGoogle Scholar
• 9 Szinnai G. Clinical genetics of congenital hypothyroidism. Endocr Dev 2014; 26: 60-78
  PubMedGoogle Scholar
• 10 Weber G, Rabbiosi S, Zamproni I, Fugazzola L. Genetic defects of hydrogen peroxide generation in the thyroid gland. J Endocrinol Invest 2013; 36: 261-266
  PubMedGoogle Scholar
• 11 Parks JS, Lin M, Grosse SD, Hinton CF, Drummond-Borg M, Borgfeld L, Sullivan KM. The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics 2010; 125 (Suppl. 02) S54-S63
  CrossrefPubMedGoogle Scholar
• 12 Sarkhail P, Mehran L, Askari S, Tahmasebinejad Z, Tohidi M, Azizi F. Maternal Thyroid Function and Autoimmunity in 3 Trimesters of Pregnancy and their Offspring’s Thyroid Function. Horm Metab Res 2016; 48: 20-26
  Article in Thieme ConnectPubMedGoogle Scholar
• 13 Maruo Y, Takahashi H, Soeda I, Nishikura N, Matsui K, Ota Y, Mimura Y, Mori A, Sato H, Takeuchi Y. Transient congenital hypothyroidism caused by biallelic mutations of the dual oxidase 2 gene in Japanese patients detected by a neonatal screening program. J Clin Endocrinol Metab 2008; 93: 4261-4267
  CrossrefPubMedGoogle Scholar
• 14 Jin HY, Heo SH, Kim YM, Kim GH, Choi JH, Lee BH, Yoo HW. High frequency of DUOX2 mutations in transient or permanent congenital hypothyroidism with eutopic thyroid glands. Horm Res Paediatr 2014; 82: 252-260
  CrossrefPubMedGoogle Scholar
• 15 Muzza M, Rabbiosi S, Vigone MC, Zamproni I, Cirello V, Maffini MA, Maruca K, Schoenmakers N, Beccaria L, Gallo F, Park SM, Beck-Peccoz P, Persani L, Weber G, Fugazzola L. The clinical and molecular characterization of patients with dyshormonogenic congenital hypothyroidism reveals specific diagnostic clues for DUOX2 defects. J Clin Endocrinol Metab 2014; 99: E544-E553
  CrossrefPubMedGoogle Scholar
• 16 Maruo Y, Nagasaki K, Matsui K, Mimura Y, Mori A, Fukami M, Takeuchi Y. Natural course of congenital hypothyroidism by dual oxidase 2 mutations from the neonatal period through puberty. Eur J Endocrinol 2016; 174: 453-463
  CrossrefPubMedGoogle Scholar
• 17 Sui HX, Li JW, Mao WF, Zhu JH, He YN, Song XY, Ma N, Zhang L, Liu SN, Liu ZP, Li FQ. Dietary iodine intake in the Chinese population. Biomed Environ Sci 2011; 24: 617-623
  PubMedGoogle Scholar
• 18 De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE, Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 2000; 275: 23227-23233
  CrossrefPubMedGoogle Scholar
• 19 De Marco G, Agretti P, Montanelli L, Di Cosmo C, Bagattini B, De Servi M, Ferrarini E, Dimida A, Freitas FA, Molinaro A, Ceccarelli C, Brozzi F, Pinchera A, Vitti P, Tonacchera M. Identification and functional analysis of novel dual oxidase 2 (DUOX2) mutations in children with congenital or subclinical hypothyroidism. J Clin Endocrinol Metab 2011; 96: E1335-E1339
  CrossrefPubMedGoogle Scholar
• 20 Wang F, Lu K, Yang Z, Zhang S, Lu W, Zhang L, Liu S, Yan S. Genotypes and phenotypes of congenital goitre and hypothyroidism caused by mutations in dual oxidase 2 genes. Clin Endocrinol (Oxf) 2014; 81: 452-457
  CrossrefPubMedGoogle Scholar
• 21 Narumi S, Muroya K, Asakura Y, Aachi M, Hasegawa T. Molecular basis of thyroid dyshormonogenesis: genetic screening in population-based Japanese patients. J Clin Endocrinol Metab 2011; 96: E1838-E1842
  CrossrefPubMedGoogle Scholar
• 22 Fu C, Zhang S, Su J, Luo S, Zheng H, Wang J, Qin H, Chen Y, Shen Y, Hu X, Fan X, Luo J, Xie B, Chen R, Chen S. Mutation screening of DUOX2 in Chinese patients with congenital hypothyroidism. J Endocrinol Invest 2015; 38: 1219-1224
  CrossrefPubMedGoogle Scholar
• 23 Consensus statement on the diagnosis and management of congenital hypothyroidism. Zhonghua Er Ke Za Zhi 2011; 49: 421-424
  PubMedGoogle Scholar
• 24 Deladoey J, Ruel J, Giguere Y, Van Vliet G. Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective population-based study in Quebec. J Clin Endocrinol Metab 2011; 96: 2422-2429
  CrossrefPubMedGoogle Scholar
• 25 Olivieri A, Fazzini C, Medda E. Multiple factors influencing the incidence of congenital hypothyroidism detected by neonatal screening. Horm Res Paediatr 2015; 83: 86-93
  CrossrefPubMedGoogle Scholar
• 26 Chiesa A, Prieto L, Mendez V, Papendieck P, Calcagno ML, Gruneiro-Papendieck L. Prevalence and etiology of congenital hypothyroidism detected through an argentine neonatal screening program (1997–2010). Horm Res Paediatr 2013; 80: 185-192
  CrossrefPubMedGoogle Scholar
• 27 Pfarr N, Korsch E, Kaspers S, Herbst A, Stach A, Zimmer C, Pohlenz J. Congenital hypothyroidism caused by new mutations in the thyroid oxidase 2 (THOX2) gene. Clin Endocrinol (Oxf) 2006; 65: 810-815
  CrossrefPubMedGoogle Scholar
• 28 Kasahara T, Narumi S, Okasora K, Takaya R, Tamai H, Hasegawa T. Delayed onset congenital hypothyroidism in a patient with DUOX2 mutations and maternal iodine excess. Am J Med Genet A 2013; 161A: 214-217
  PubMedGoogle Scholar
• 29 Moreno JC, Bikker H, Kempers MJ, van Trotsenburg AS, Baas F, de Vijlder JJ, Vulsma T, Ris-Stalpers C. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 2002; 347: 95-102
  CrossrefPubMedGoogle Scholar
• 30 Hoste C, Rigutto S, Van Vliet G, Miot F, De Deken X. Compound heterozygosity for a novel hemizygous missense mutation and a partial deletion affecting the catalytic core of the H2O2-generating enzyme DUOX2 associated with transient congenital hypothyroidism. Hum Mutat 2010; 31: E1304-E1319
  CrossrefPubMedGoogle Scholar
• 31 Vigone MC, Fugazzola L, Zamproni I, Passoni A, Di Candia S, Chiumello G, Persani L, Weber G. Persistent mild hypothyroidism associated with novel sequence variants of the DUOX2 gene in two siblings. Hum Mutat 2005; 26: 395
  PubMedGoogle Scholar
• 32 Rigutto S, Hoste C, Grasberger H, Milenkovic M, Communi D, Dumont JE, Corvilain B, Miot F, De Deken X. Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation. J Biol Chem 2009; 284: 6725-6734
  CrossrefPubMedGoogle Scholar
• 33 Yoshizawa-Ogasawara A, Abe K, Ogikubo S, Narumi S, Hasegawa T, Satoh M. Transient congenital hypothyroidism caused by compound heterozygous mutations affecting the NADPH-oxidase domain of DUOX2. J Pediatr Endocrinol Metab 2016; 29: 363-371
  PubMedGoogle Scholar
• 34 Zheng X, Ma SG, Qiu YL, Guo ML, Shao XJ. A Novel c.554+5C>T Mutation in the DUOXA2 Gene Combined with p.R885Q Mutation in the DUOX2 Gene Causing Congenital Hypothyroidism. J Clin Res Pediatr Endocrinol 2016; 8: 224-227
  CrossrefPubMedGoogle Scholar
• 35 Satoh M, Aso K, Ogikubo S, Yoshizawa-Ogasawara A, Saji T. Hypothyroidism caused by the combination of two heterozygous mutations: one in the TSH receptor gene the other in the DUOX2 gene. J Pediatr Endocrinol Metab 2015; 28: 657-661
  PubMedGoogle Scholar
• 36 Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351: 241-249
  CrossrefPubMedGoogle Scholar

• Supplementary Material